Avacincaptad pegol Uses, Dosage, Side Effects and more

Avacincaptad pegol is under investigation in clinical trial NCT03362190 (ZIMURA in Combination With LUCENTIS in Patients With Neovascular Age Related Macular Degeneration (NVAMD)).

Trade Name Avacincaptad pegol
Generic Avacincaptad pegol
Avacincaptad pegol Other Names Avacincaptad pegol
Type
Groups Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated: January 7, 2025 at 1:49 am

Innovators Monograph


*** Taking medicines without doctor's advice can cause long-term problems.
Share